Logo image of CGX.CA

CINEPLEX INC (CGX.CA) Stock Fundamental Analysis

TSX:CGX - Toronto Stock Exchange - CA1724541000 - Common Stock - Currency: CAD

10.59  -0.06 (-0.56%)

Fundamental Rating

3

Overall CGX gets a fundamental rating of 3 out of 10. We evaluated CGX against 13 industry peers in the Entertainment industry. CGX has a medium profitability rating, but doesn't score so well on its financial health evaluation. CGX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CGX has reported negative net income.
In the past year CGX had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CGX reported negative net income in multiple years.
CGX had a positive operating cash flow in 4 of the past 5 years.
CGX.CA Yearly Net Income VS EBIT VS OCF VS FCFCGX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.26%, CGX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CGX has a Return On Invested Capital of 1.76%. This is in the better half of the industry: CGX outperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA -2.26%
ROE N/A
ROIC 1.76%
ROA(3y)-1.47%
ROA(5y)-6.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CGX.CA Yearly ROA, ROE, ROICCGX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

CGX's Profit Margin has improved in the last couple of years.
CGX's Operating Margin of 3.82% is fine compared to the rest of the industry. CGX outperforms 75.00% of its industry peers.
In the last couple of years the Operating Margin of CGX has grown nicely.
The Gross Margin of CGX (65.99%) is better than 100.00% of its industry peers.
CGX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.82%
PM (TTM) N/A
GM 65.99%
OM growth 3YN/A
OM growth 5Y5.23%
PM growth 3YN/A
PM growth 5Y20.28%
GM growth 3Y-0.15%
GM growth 5Y0.32%
CGX.CA Yearly Profit, Operating, Gross MarginsCGX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

1

2. Health

2.1 Basic Checks

CGX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CGX has more shares outstanding
The number of shares outstanding for CGX has been increased compared to 5 years ago.
The debt/assets ratio for CGX has been reduced compared to a year ago.
CGX.CA Yearly Shares OutstandingCGX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CGX.CA Yearly Total Debt VS Total AssetsCGX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

CGX has an Altman-Z score of -0.06. This is a bad value and indicates that CGX is not financially healthy and even has some risk of bankruptcy.
CGX has a Altman-Z score (-0.06) which is comparable to the rest of the industry.
The Debt to FCF ratio of CGX is 34.41, which is on the high side as it means it would take CGX, 34.41 years of fcf income to pay off all of its debts.
CGX has a Debt to FCF ratio of 34.41. This is comparable to the rest of the industry: CGX outperforms 58.33% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 34.41
Altman-Z -0.06
ROIC/WACC0.32
WACC5.51%
CGX.CA Yearly LT Debt VS Equity VS FCFCGX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.30 indicates that CGX may have some problems paying its short term obligations.
With a Current ratio value of 0.30, CGX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CGX has a Quick Ratio of 0.30. This is a bad value and indicates that CGX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.26, CGX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.26
CGX.CA Yearly Current Assets VS Current LiabilitesCGX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The earnings per share for CGX have decreased strongly by -466.67% in the last year.
The Earnings Per Share has been growing by 8.30% on average over the past years. This is quite good.
CGX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -28.45%.
CGX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.94% yearly.
EPS 1Y (TTM)-466.67%
EPS 3YN/A
EPS 5Y8.3%
EPS Q2Q%-234.48%
Revenue 1Y (TTM)-28.45%
Revenue growth 3Y49.19%
Revenue growth 5Y-2.94%
Sales Q2Q%-14.67%

3.2 Future

CGX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 98.92% yearly.
The Revenue is expected to decrease by -1.07% on average over the next years.
EPS Next Y-95.69%
EPS Next 2Y176.24%
EPS Next 3Y98.92%
EPS Next 5YN/A
Revenue Next Year-14.84%
Revenue Next 2Y-2.59%
Revenue Next 3Y-1.07%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGX.CA Yearly Revenue VS EstimatesCGX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
CGX.CA Yearly EPS VS EstimatesCGX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4 -6

4

4. Valuation

4.1 Price/Earnings Ratio

CGX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 11.75 indicates a reasonable valuation of CGX.
Based on the Price/Forward Earnings ratio, CGX is valued cheaper than 91.67% of the companies in the same industry.
CGX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 94.77.
Industry RankSector Rank
PE N/A
Fwd PE 11.75
CGX.CA Price Earnings VS Forward Price EarningsCGX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

CGX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CGX is cheaper than 75.00% of the companies in the same industry.
CGX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 12.33
EV/EBITDA 11.87
CGX.CA Per share dataCGX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

CGX's earnings are expected to grow with 98.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y176.24%
EPS Next 3Y98.92%

0

5. Dividend

5.1 Amount

CGX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CINEPLEX INC

TSX:CGX (2/7/2025, 7:00:00 PM)

10.59

-0.06 (-0.56%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)02-11 2025-02-11/amc
Inst Owners29.21%
Inst Owner ChangeN/A
Ins Owners1.73%
Ins Owner ChangeN/A
Market Cap671.19M
Analysts78
Price Target13.86 (30.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-193.89%
Min EPS beat(2)-413.09%
Max EPS beat(2)25.32%
EPS beat(4)2
Avg EPS beat(4)-1281.02%
Min EPS beat(4)-4852.48%
Max EPS beat(4)116.17%
EPS beat(8)4
Avg EPS beat(8)-631.73%
EPS beat(12)6
Avg EPS beat(12)-389.18%
EPS beat(16)8
Avg EPS beat(16)-302.34%
Revenue beat(2)1
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)1.26%
Revenue beat(4)2
Avg Revenue beat(4)-3.55%
Min Revenue beat(4)-13.64%
Max Revenue beat(4)1.26%
Revenue beat(8)6
Avg Revenue beat(8)-0.29%
Revenue beat(12)9
Avg Revenue beat(12)0.24%
Revenue beat(16)11
Avg Revenue beat(16)-2.36%
PT rev (1m)1.24%
PT rev (3m)4.49%
EPS NQ rev (1m)19.34%
EPS NQ rev (3m)42.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-500%
Revenue NQ rev (1m)-3.96%
Revenue NQ rev (3m)-2.42%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.75
P/S 0.59
P/FCF 12.33
P/OCF 5.4
P/B N/A
P/tB N/A
EV/EBITDA 11.87
EPS(TTM)-0.88
EYN/A
EPS(NY)0.9
Fwd EY8.51%
FCF(TTM)0.86
FCFY8.11%
OCF(TTM)1.96
OCFY18.53%
SpS17.81
BVpS-0.63
TBVpS-11.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.26%
ROE N/A
ROCE 2.44%
ROIC 1.76%
ROICexc 1.79%
ROICexgc 3%
OM 3.82%
PM (TTM) N/A
GM 65.99%
FCFM 4.82%
ROA(3y)-1.47%
ROA(5y)-6.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-12.89%
ROICexc growth 3YN/A
ROICexc growth 5Y-2.34%
OM growth 3YN/A
OM growth 5Y5.23%
PM growth 3YN/A
PM growth 5Y20.28%
GM growth 3Y-0.15%
GM growth 5Y0.32%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 34.41
Debt/EBITDA 8.42
Cap/Depr 41.4%
Cap/Sales 6.19%
Interest Coverage 0.32
Cash Conversion 58.67%
Profit Quality N/A
Current Ratio 0.3
Quick Ratio 0.26
Altman-Z -0.06
F-Score4
WACC5.51%
ROIC/WACC0.32
Cap/Depr(3y)29.39%
Cap/Depr(5y)35.37%
Cap/Sales(3y)5.43%
Cap/Sales(5y)9.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-466.67%
EPS 3YN/A
EPS 5Y8.3%
EPS Q2Q%-234.48%
EPS Next Y-95.69%
EPS Next 2Y176.24%
EPS Next 3Y98.92%
EPS Next 5YN/A
Revenue 1Y (TTM)-28.45%
Revenue growth 3Y49.19%
Revenue growth 5Y-2.94%
Sales Q2Q%-14.67%
Revenue Next Year-14.84%
Revenue Next 2Y-2.59%
Revenue Next 3Y-1.07%
Revenue Next 5YN/A
EBIT growth 1Y-75.66%
EBIT growth 3YN/A
EBIT growth 5Y2.14%
EBIT Next Year52.09%
EBIT Next 3Y26.06%
EBIT Next 5Y14.69%
FCF growth 1Y138.9%
FCF growth 3YN/A
FCF growth 5Y13.34%
OCF growth 1Y65.78%
OCF growth 3YN/A
OCF growth 5Y1.63%